Morocco

Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Morocco is regulated by the MAPHAR (Direction du Médicament). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

MAPHAR (Direction du Médicament)

Regulatory Pathways (1)

MAPHAR Autorisation Exceptionnelle d'Importation – Morocco 30 days

Morocco's Direction du Médicament (MAPHAR) exceptional import authorization for unregistered medicines for patients with serious medical needs.

Application Form: MAPHAR Exceptional Import Form

Legal Basis: Dahir No. 1-06-151 (Moroccan Drug Law)

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: MAPHAR Drug Import Guidelines

Morocco

ISO Code	`MA`
Region	Africa
Regulatory Authority	MAPHAR (Direction du Médicament)
Pathways	1 documented
Drugs Available	0 documented